News & Analysis on Clinical Trial Services & Contract Research And Development
A class of drug, which is currently used to fight respiratory tract infections, has demonstrated pharmacological features and potential antibacterial drug activity that may prove effective against Tuberculosis, which is currently experiencing a...
Drug company Merck, has presented data this week showing its latest arthrirtis drug, Arcoxia, a treatment in the same class as its recently withdrawn Vioxx, displays no significant difference in the number of serious side effects than those treated...
After over fifteen years of consolidation, the pharmaceutical industry may have reached a 'steady state', or even be facing future fragmentation.
Tecan Europe has made available the LabCD, a centrifugally driven microfluidics disc platform which the makers say will provide a seamless in vitro method for ADMET applications in the drug development process.
German biotech company Evotec OAI posted decreased third quarterly revenues of €16.1 million, down 26 per cent compared to 2003. Evotec's performance reflects the difficult operating environment for companies supplying drug discovery technologies.
Finnish packaging giant Huhtamaki has reported flat sales figures in the third quarter of 2004 due to adverse currency translations and high raw material costs.